Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine

NEXT STORY
LIDDS Interim report January – December 2020
PREV STORY
Brandywine Realty Trust Announces Common Quarterly Dividend, and Confirms First Quarter 2021 Earnings Release and Conference Call
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Gritstone Oncology Announces Pricing of Initial Public Offering

EMERYVILLE, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq:GRTS) today announced ...

author_avatar
NASDAQ Market News

Recro Pharma Announces Successful Top-Line Results from Phase III Safety Study of IV Meloxicam

IV Meloxicam 30mg Continues to Demonstrate Solid Safety and Tolerability Profile Company on Track ...

author_avatar
NASDAQ Market News

Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China

PLYMOUTH MEETING, Pa., March 20, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

author_avatar
NASDAQ Market News